15 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/15/2946281/0/en/MacroGenics-Announces-Updated-Efficacy-Safety-Data-from-TAMARACK-Phase-2-Study-of-Vobra-Duo-in-mCRPC-Patients-at-ESMO-Congress-2024.html
08 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/08/2942475/0/en/MacroGenics-Announces-TAMARACK-Phase-2-Data-Presentation-at-ESMO-Congress-2024.html
30 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/30/2921390/0/en/MacroGenics-Provides-Vobramitamab-Duocarmazine-Update.html
11 May 2024
// Nick Paul Taylor FIERCE PHARMA
https://www.fiercebiotech.com/biotech/macrogenics-stock-crashes-after-5-deaths-seen-adc-trial
19 Sep 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/byondis-esmo-late-breaking-presentation-confirms-adc-vic--trastuzumab-duocarmazine-syd985-superior-to-physicians-choice-in-pre-treated-locally-advanced-or-metastatic-her2-positive-breast-cancer-301379760.html
LOOKING FOR A SUPPLIER?